Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: Clinical outcomes in a context of specialized oral care using low-level laser therapy

Fernanda De Paula Eduardo, Leticia Mello Bezinelli, Danielle Lima Corrêa De Carvalho, Roberta Marques Da Graça Lopes, Juliana Folloni Fernandes, Melina Brumatti, Carolina Sgaroni Camargo Vince, Alessandra Milani Prandini De Azambuja, Cristina Vogel, Nelson Hamerschlak, Luciana Correa

    Research output: Contribution to journalArticle

    19 Scopus citations

    Abstract

    OM is a painful inflammatory condition of the oral mucosa, derived from the toxic effects of chemotherapy and radiotherapy. High OM severity is frequently present in HSCT pediatric patients, who exhibit multiple painful ulcers that limit their mastication and swallowing, leading to poor nutritional status. Few studies have demonstrated OM clinical outcomes in young patients undergoing HSCT. Feasibility of oral care and LLLT on OM prophylaxis and treatment is also poorly discussed. The aim of this study was to describe a specialized oral care protocol that included LLLT for pediatric patients undergoing transplantation and to demonstrate the clinical outcomes after OM prevention and treatment. Data from OM-related morbidity were collected from 51 HSCT pediatric patients treated daily with LLLT, followed by standard oral care protocols. All the patients, even infants and young children, accepted the daily oral care and LLLT well. The majority (80.0%) only exhibited erythema in the oral mucosa, and the maximum OM degree was WHO II. Patients who had undergone autologous and HLA-haploidentical transplants showed OM with the lowest severity. The frequency of total body irradiation and methotrexate prescriptions was higher in adolescents when compared with infants (p = 0.044), and adolescents also exhibited OM more severely than infants and young children. We found that good clinical outcomes were obtained using this therapy, mainly in regard to the control of OM severity and pain reduction in the oral cavity. Specialized oral care, including LLLT, is feasible and affordable for HSCT pediatric patients, although some adaptation in the patient's oral hygiene routine must be adopted with help from parents/companions and clinical staff.

    Original languageEnglish (US)
    Pages (from-to)316-325
    Number of pages10
    JournalPediatric Transplantation
    Volume19
    Issue number3
    DOIs
    StatePublished - May 1 2015

    Keywords

    • hematopoietic stem cell transplantation
    • low-level laser therapy
    • oral health care
    • oral mucositis
    • pediatric patients

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Transplantation

    Fingerprint Dive into the research topics of 'Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: Clinical outcomes in a context of specialized oral care using low-level laser therapy'. Together they form a unique fingerprint.

  • Cite this

    Eduardo, F. D. P., Bezinelli, L. M., De Carvalho, D. L. C., Lopes, R. M. D. G., Fernandes, J. F., Brumatti, M., Vince, C. S. C., De Azambuja, A. M. P., Vogel, C., Hamerschlak, N., & Correa, L. (2015). Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: Clinical outcomes in a context of specialized oral care using low-level laser therapy. Pediatric Transplantation, 19(3), 316-325. https://doi.org/10.1111/petr.12440